For the quarter ending 2026-03-31, RPID made $8,002K in revenue. -$14,275K in net income. Net profit margin of -178.39%.
| Income Statement | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
|---|---|---|---|---|
| Total revenue | 8,002 | 10,937* | 7,838 | 7,262 |
| Product | 6,025 | 9,661* | 5,563 | 5,315 |
| Service | 1,606 | 1,685* | 1,579 | 1,672 |
| Total cost of revenue | 7,631 | - | - | - |
| Gross margin | 371 | - | - | - |
| Research and development | 3,359 | 3,465* | 3,529 | 3,230 |
| Sales and marketing | 3,422 | 3,069* | 2,895 | 3,114 |
| General and administrative | 7,442 | 5,170* | 5,644 | 6,079 |
| Total costs and operating expenses | - | 23,048* | 19,210 | 19,410 |
| Total operating expenses | 14,223 | - | - | - |
| Loss from operations | -13,852 | -12,111* | -11,372 | -12,148 |
| Interest income | 256 | -127* | 347 | - |
| Interest expense | 639 | -89* | 393 | - |
| Other expense, net | -32 | 84* | -79 | -50 |
| Interest income, net | - | - | - | 351 |
| Total other income (expense), net | -415 | 45* | -125 | 301 |
| Loss before income taxes | -14,267 | -12,066* | -11,497 | -11,847 |
| Federal | - | 0* | - | - |
| State | - | 0* | - | - |
| Foreign | - | 10* | - | - |
| Total current income tax expense | - | 10* | - | - |
| Federal | - | 2,509* | - | - |
| State | - | 347* | - | - |
| Foreign | - | 0* | - | - |
| Total deferred income tax provision | - | 2,856* | - | - |
| Change in deferred tax asset valuation allowance | - | 2,854* | - | - |
| Income tax expense | 8 | 12* | 8 | 11 |
| Net loss | -14,275 | -12,078 | -11,505 | -11,858 |
| Basic EPS | -0.31 | -0.272 | -0.26 | -0.27 |
| Diluted EPS | -0.31 | -0.272 | -0.26 | -0.27 |
| Basic Average Shares | 45,433,800 | 44,433,290 | 44,956,131 | 44,648,602 |
| Diluted Average Shares | 45,433,800 | 44,433,290 | 44,956,131 | 44,648,602 |
RAPID MICRO BIOSYSTEMS, INC. (RPID)
RAPID MICRO BIOSYSTEMS, INC. (RPID)